<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Candidemia and invasive candidiasis in children: Clinical manifestations and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Candidemia and invasive candidiasis in children: Clinical manifestations and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Candidemia and invasive candidiasis in children: Clinical manifestations and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Judith R Campbell, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Debra L Palazzi, MD, MEd</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 21, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The term candidemia describes the presence of <em>Candida</em> species in the blood. <em>Candida</em> in a blood culture should prompt a search for the source; it should never be viewed as a contaminant. Invasive candidiasis encompasses both candidemia and deep-seated (ie, visceral) candidiasis (which may occur with or without candidemia) [<a href="#rid1">1</a>].</p><p>The epidemiology, pathogenesis, clinical manifestations, and diagnosis of candidemia and invasive candidiasis in children will be discussed here. An overview of candidal infections and management of candidemia and invasive candidiasis in children, candidal infections in neonates, and candidal infections in adults are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5972.html" rel="external">"Candida infections in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6014.html" rel="external">"Candidemia and invasive candidiasis in children: Management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5028.html" rel="external">"Epidemiology and risk factors for Candida infection in neonates"</a> and  <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">"Clinical manifestations and diagnosis of Candida infection in neonates"</a> and  <a class="medical medical_review" href="/z/d/html/5029.html" rel="external">"Treatment of Candida infection in neonates"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2442.html" rel="external">"Candidemia in adults: Epidemiology, microbiology, and pathogenesis"</a> and  <a class="medical medical_review" href="/z/d/html/2462.html" rel="external">"Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2430.html" rel="external">"Management of candidemia and invasive candidiasis in adults"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Beyond the neonatal period (ie, in children &gt;28 days),<em> Candida</em> spp are important pathogens in critically ill patients and patients with immunocompromising conditions [<a href="#rid2">2-4</a>]. The epidemiology of <em>Candida</em> infections in neonates is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5028.html" rel="external">"Epidemiology and risk factors for Candida infection in neonates"</a>.)</p><p>The overall incidence of candidemia in population-based studies ranges from 1 to 17.5 cases per 100,000 persons [<a href="#rid5">5-10</a>]. The incidence is increased in children younger than one year and in older adults [<a href="#rid9">9,10</a>]. In population-based surveillance in the United States in 2017, the estimated incidence of candidemia was 7.7 per 100,000 in infants &lt;1 year of age and 0.3 per 100,000 in children age 1 through 18 years [<a href="#rid9">9</a>]. In surveillance from a single tertiary care children's hospital, <em>Candida</em> accounted for 5 percent of episodes of bloodstream infections between 2002 and 2012 [<a href="#rid11">11</a>].</p><p>The infecting strain usually is part of the host's colonizing flora [<a href="#rid12">12</a>], although acquisition of <em>Candida auris</em> appears to be exogenous [<a href="#rid13">13,14</a>]. Health care-associated acquisition of <em>Candida</em> species has been described but is rare. In health care-associated cases, contaminated solutions and the hands of health care workers have been implicated [<a href="#rid12">12,15</a>].</p><p>The distribution of <em>Candida</em> spp causing invasive candidiasis varies geographically and temporally. Although <em>Candida albicans</em> is isolated most frequently, nonalbicans species are increasingly isolated at some institutions [<a href="#rid4">4-6,16-19</a>]. In children, <em>Candida parapsilosis</em> is the predominant nonalbicans species in most geographic regions [<a href="#rid4">4,5,20,21</a>].</p><p><em>C. auris</em> candidemia remains rare in children but has been reported in children in Venezuela, Colombia, India, South Africa, and South Korea [<a href="#rid22">22-24</a>]. It has been associated with serious infection, multidrug resistance, health care outbreaks, and misidentification [<a href="#rid14">14</a>].</p><p>In adults, <em>Candida glabrata</em> is the predominant nonalbicans species in Canada, northern Europe, and the United States, whereas <em>C. parapsilosis</em> is more prominent in Asia, southern Europe, and South America [<a href="#rid7">7</a>]. Increasing use of <a class="drug drug_pediatric" data-topicid="13303" href="/z/d/drug information/13303.html" rel="external">fluconazole</a> may contribute to the increasing prevalence of nonalbicans species, but other factors may also play a role [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H3"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>Immunosuppressed children, children in intensive care units, children with central venous catheters, and neonates are most at risk for the development of candidemia. Risk factors in neonates are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5028.html" rel="external">"Epidemiology and risk factors for Candida infection in neonates", section on 'Risk factors for invasive candidiasis'</a>.)</p><p>Risk factors for invasive candidiasis in children beyond the neonatal period and adolescents include [<a href="#rid3">3,5,25-28</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Central venous catheter</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immune suppression (eg, hematologic malignancy; solid organ or stem cell transplantation; antineoplastic chemotherapy; neutropenia; long-term glucocorticoids)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Damage to the gastrointestinal mucosa (eg, related to antineoplastic chemotherapy or immune modulators, abdominal surgery, gastrointestinal perforation or anastomotic leak)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Broad-spectrum antibiotics</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Parenteral nutrition</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Kidney failure requiring hemodialysis</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mechanical ventilation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Genetic susceptibility [<a href="#rid29">29-31</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Injection drug use [<a href="#rid32">32,33</a>]</p><p></p><p>A multivariate model using several of the above risk factors failed to predict candidemia in a multicenter case control study [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H7"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span><em>Candida</em> gains access to the bloodstream by three major routes:</p><p class="bulletIndent1"><span class="glyph">●</span>Through the gastrointestinal tract mucosal barrier (most common mechanism for candidemia) – <em>Candida</em> species are part of the normal bowel flora; predisposing factors (eg, broad-spectrum antibiotics, immune suppression, gastrointestinal surgery) lead to overgrowth and subsequent leakage into the bloodstream. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Via an intravascular catheter, particularly a central venous catheter – <em>Candida</em> colonization of the vascular catheter can occur at either the insertion site or the hub, and lead to subsequent candidemia. Candidemia that originated in the gut or skin also can colonize the catheter during bloodstream infection. Colonization of the catheter may lead to the formation of a biofilm, from which fungi are subsequently released, resulting in persistent candidemia while the catheter is in place [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>From a localized focus of infection (eg, pyelonephritis) – Bloodstream invasion is relatively uncommon from a localized focus of infection but has been well described with ascending <em>Candida</em> urinary tract infection associated with either intrinsic obstruction (eg, from a fungus ball) or extrinsic compression preventing the flow of infected urine. (See  <a class="medical medical_review" href="/z/d/html/2415.html" rel="external">"Candida infections of the bladder and kidneys"</a> and  <a class="medical medical_review" href="/z/d/html/5972.html" rel="external">"Candida infections in children", section on 'Urinary tract infections'</a>.) </p><p></p><p class="bulletIndent1"><em>Candida</em> may disseminate from the localized infection, leading to metastatic infections in the lung, liver, spleen, kidneys, bone, or eye (ie, deep-seated infections). Deep-seated infections may remain localized or lead to secondary candidemia [<a href="#rid7">7</a>]. Other focal Candida infections in children are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5972.html" rel="external">"Candida infections in children", section on 'Invasive focal infections'</a>.)</p><p></p><p class="headingAnchor" id="H8"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The clinical manifestations of candidemia and invasive candidiasis vary from minimal fever to a fulminant sepsis with multiorgan system failure that is indistinguishable from severe bacterial infection. In patients with fulminant sepsis, necropsy reveals widespread visceral microabscesses that are especially prominent in the kidneys (<a class="graphic graphic_picture graphicRef52139" href="/z/d/graphic/52139.html" rel="external">picture 1</a>), heart, liver, spleen, lungs, and brain.</p><p>Clinical clues to candidemia include characteristic ocular lesions, skin lesions, and, less commonly, muscle abscesses.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ocular involvement</strong> – Characteristic chorioretinal findings include focal, glistening, white, infiltrative, often mound-like lesions on the retina (<a class="graphic graphic_picture graphicRef58685" href="/z/d/graphic/58685.html" rel="external">picture 2A</a>). A vitreal haze suggests extension to the vitreous (endophthalmitis); sometimes fluffy white balls or "snowballs" in the vitreous are noted (<a class="graphic graphic_picture graphicRef73318" href="/z/d/graphic/73318.html" rel="external">picture 2B</a>). (See  <a class="medical medical_review" href="/z/d/html/16953.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of fungal endophthalmitis", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent1">After the neonatal period, ocular candidiasis is uncommon; it may be seen in children who are immunocompromised. In a retrospective review, among 254 children with candidemia who had a dilated retinal examination, only eight patients (3.2 percent) had ophthalmologic involvement: four had chorioretinitis only and four had involvement of the vitreous in addition to chorioretinitis [<a href="#rid35">35</a>]. Neonatal chorioretinitis is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">"Clinical manifestations and diagnosis of Candida infection in neonates", section on 'Ocular involvement'</a>.)</p><p></p><p class="bulletIndent1">Chorioretinitis and endophthalmitis can be caused by pathogens other than <em>Candida</em>. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Skin lesions</strong> – Invasive candidal skin lesions tend to appear suddenly as clusters of painless pustules on an erythematous base; they can occur on any area of the body. The lesions vary from tiny pustules that can be easily missed (<a class="graphic graphic_picture graphicRef55977" href="/z/d/graphic/55977.html" rel="external">picture 3A</a>) to nodular lesions several centimeters in diameter, which appear necrotic in the center (<a class="graphic graphic_picture graphicRef75717" href="/z/d/graphic/75717.html" rel="external">picture 3B</a>). In severely neutropenic patients, the lesions may be macular rather than pustular.</p><p></p><p class="bulletIndent1">Specimens from skin lesions (eg, scrapings from the base of a pustule, punch biopsy) can be obtained for laboratory identification to distinguish <em>Candida</em> from other causes of pustular skin lesions. (See <a class="local">'Culture and stain of biopsy material'</a> below and <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Muscle pain</strong> – Soreness in a discrete muscle group is less common than chorioretinitis or skin lesions. Examination reveals a tender muscle that may be warm and swollen. Biopsy shows microabscesses in the muscle, and special stains may show budding yeasts.</p><p></p><p>Clinical manifestations of deep-seated candidal infections that may or may not be associated with candidemia are described separately. (See  <a class="medical medical_review" href="/z/d/html/5972.html" rel="external">"Candida infections in children", section on 'Invasive focal infections'</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">EVALUATION</span></p><p class="headingAnchor" id="H2223395804"><span class="h2">Clinical suspicion</span><span class="headingEndMark"> — </span>Although many children with invasive candidiasis have no obvious clinical manifestations, we suspect candidemia or invasive candidiasis in children with risk factors who have [<a href="#rid36">36</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Unexplained fever or signs of severe sepsis while receiving adequate antibiotics</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skin lesions suggestive of invasive candidiasis (eg, multiple, nontender, erythematous, pustular or nodular lesions (<a class="graphic graphic_picture graphicRef55977 graphicRef75717" href="/z/d/graphic/55977.html" rel="external">picture 3A-B</a>))</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Eye findings suggestive of invasive candidiasis (<a class="graphic graphic_picture graphicRef58685 graphicRef73318" href="/z/d/graphic/58685.html" rel="external">picture 2A-B</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multiple focal liver or spleen lesions on imaging for persistent fever [<a href="#rid37">37,38</a>]</p><p></p><p>Decisions regarding empiric treatment with antifungal therapy in children with suspected candidemia (whether or not they have suggestive examination findings) are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6014.html" rel="external">"Candidemia and invasive candidiasis in children: Management", section on 'Empiric antifungal therapy for at-risk patients'</a>.)</p><p class="headingAnchor" id="H4110221919"><span class="h2">Approach to laboratory diagnosis</span><span class="headingEndMark"> — </span>The tests available to detect invasive candidiasis have important limitations; accurate diagnosis may require multiple tests [<a href="#rid1">1,7,39</a>].</p><p>We suggest the following approach to laboratory diagnosis in children with suspected candidemia:</p><p class="bulletIndent1"><span class="glyph">●</span>All patients – Obtain aerobic blood cultures (routine bacterial cultures) of adequate volume based on the patient's weight from peripheral and central catheters whenever feasible. Repeat daily blood cultures are of limited clinical utility if the initial culture or set of cultures are of adequate volume and the patient's clinical condition is unchanged. The sensitivity of detection varies by pathogen and disease [<a href="#rid40">40</a>], as well as blood culture volume. The optimal volume for detection of <em>Candida</em> is not known. Although many institutions have their own guidelines for blood culture volume, <strong>general guidelines</strong> for adequate volume according to the patient's body weight are as follows [<a href="#rid41">41</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>≤1 kg – 2 mL (only one aerobic culture is obtained)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>1.1 to 2 kg – 2 mL for first culture and 2 mL for second culture (each culture is aerobic only)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>2.1 to 12.7 kg – 4 mL for first culture and 2 mL for second culture (each culture is aerobic only)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>12.8 to 36.3 kg – 10 mL for first culture and 10 mL for second culture (each culture is aerobic only)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>&gt;36.3 kg – 20 to 30 mL for first culture set and 20 to 30 mL for second culture set; each culture set may require two or more aerobic culture bottles depending upon the manufacturer</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with pustules or other skin lesions (<a class="graphic graphic_picture graphicRef55977 graphicRef75717" href="/z/d/graphic/55977.html" rel="external">picture 3A-B</a>) – Scrape the base of the pustule with a scalpel and submit obtained material for Gram stain and culture. Obtain a punch biopsy for culture, fungal stains, and histopathologic examination.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with parenchymal involvement (eg, brain, kidney) – Obtain biopsy for culture, fungal stains, and histopathologic examination.</p><p></p><p class="headingAnchor" id="H3028289430"><span class="h2">Microbiologic studies</span></p><p class="headingAnchor" id="H10"><span class="h3">Blood cultures</span><span class="headingEndMark"> — </span>A blood culture positive for <em>Candida</em> is the reference standard for the diagnosis of candidemia. Culture is the only method that allows susceptibility testing. <em>Candida</em> in a blood culture should prompt immediate treatment and a search for the source (eg, central venous catheter, gastrointestinal tract, deep-seated infection); it should never be viewed as a contaminant. (See  <a class="medical medical_review" href="/z/d/html/6014.html" rel="external">"Candidemia and invasive candidiasis in children: Management", section on 'Choice of antifungal therapy'</a>.)</p><p><em>Candida</em> can be detected with blood culture systems commonly used for the detection of bacteria, but the reported sensitivity can be low. In studies performed before the advent of modern blood culture techniques, blood cultures were positive in only approximately 50 percent of patients found to have disseminated candidiasis at autopsy [<a href="#rid1">1</a>]. Similar autopsy-based studies have not been reported since the advent of modern blood culture techniques (eg, lysis-centrifugation [Dupont Isolator tube], changes in culture media used in the BACTEC and BactiAlert systems). However, with newer automated blood culture systems and weight-based recommendations for obtaining appropriate volumes of blood for culture, the rate of detection likely is improved.</p><p>It can take several days to establish the diagnosis of candidemia with blood cultures: one to two days for the <em>Candida</em> to grow and another one to two days for speciation [<a href="#rid42">42</a>]. New techniques are helping to shorten the interval to identification:</p><p class="bulletIndent1"><span class="glyph">●</span>Peptide nucleic acid (PNA) fluorescence in situ hybridization (FISH) technology is a commercially available system that can identify yeasts as being <em>C. albicans</em> or <em>C. glabrata</em> within two hours of obtaining a positive blood culture [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) identifies protein patterns of many types of organisms accurately and quickly and is increasingly used for the rapid identification of <em>Candida </em>species isolated from blood cultures [<a href="#rid44">44</a>].</p><p></p><p class="headingAnchor" id="H11"><span class="h3">Culture and stain of biopsy material</span><span class="headingEndMark"> — </span>Culture or histopathologic examination of biopsy samples from skin or other sites of involvement may lead to identification of <em>Candida</em>. Gram stain may demonstrate budding yeast (<a class="graphic graphic_picture graphicRef70812" href="/z/d/graphic/70812.html" rel="external">picture 4</a>). Punch biopsies of skin or tissue biopsy will show microabscesses, and special stains for fungi (eg, Gomori methenamine silver, periodic acid-Schiff) will show budding yeasts and sometimes pseudohyphae or hyphae characteristic of <em>Candida</em>.</p><p>Isolation of <em>Candida</em> from skin or parenchymal biopsy is a reference standard for the diagnosis of candidiasis. As with blood cultures, the sensitivity of cultures from parenchymal samples is relatively low, reflecting the difficulties in choosing the best site for sampling and the variability in distribution and burden of viable organisms [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H12"><span class="h3">Nonculture methods</span><span class="headingEndMark"> — </span>Nonculture methods include beta-D-glucan and other antigen assays and polymerase chain reaction (PCR). Nonculture methods, alone or in combination with blood cultures may increase the identification of invasive candidiasis [<a href="#rid1">1</a>]. However, these methods are not well studied in children and we generally do not use them. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Specific for </strong><strong><em>Candida</em></strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Commercial PCR assays</strong> – The T2Candida is a US Food and Drug Administration-approved magnetic resonance-based system that is able to detect <em>Candida</em> colony-forming units and identify five <em>Candida</em> species (<em>C. albicans</em>, <em>C. tropicalis</em>, <em>C. parapsilosis</em>, <em>C. glabrata</em>, <em>C. krusei</em>) directly from blood cultures within as few as three to five hours [<a href="#rid45">45-48</a>], but data in children are limited [<a href="#rid49">49-51</a>] and further study of the clinical utility in pediatric patients is necessary. (See  <a class="medical medical_review" href="/z/d/html/2462.html" rel="external">"Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults", section on 'T2Candida'</a>.)</p><p></p><p class="bulletIndent2">The Septifast assay is another commercially available rapid PCR test that can be used on whole blood without preculture to detect and identify <em>Candida</em> species within six hours. However, it is unavailable in the United States and requires further study in children.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Noncommercial PCR assay</strong> – Experience with PCR assays for invasive candidiasis in children is limited. PCR assays can identify individual species of <em>Candida</em>. However, a standardized PCR assay for <em>Candida</em> that has been validated in multicenter studies is not yet available.</p><p></p><p class="bulletIndent2">The reported sensitivity of noncommercial ("in-house") PCR assays for the detection of candidemia is similar to that of blood cultures; however, in occasional cases PCR helped to establish the diagnosis of invasive candidiasis when cultures were negative [<a href="#rid39">39,52-54</a>].</p><p></p><p class="bulletIndent2">Newer real-time PCR assays appear to be more sensitive than blood cultures and the beta-D-glucan assay in detecting invasive candidiasis in adult patients [<a href="#rid39">39</a>]; combining PCR with blood cultures may further increase the sensitivity.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antigen and antibody assays</strong> – Assays for several <em>Candida</em> cell wall components (eg, mannan), cytoplasmic antigens, and the metabolite arabinitol have been investigated, but most are not sufficiently sensitive for diagnosis invasive candidiasis [<a href="#rid51">51,55-58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Not specific for </strong><strong><em>Candida</em></strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Beta-D-glucan</strong> – Experience with beta-D-glucan assays for the diagnosis of candidemia in children is limited.</p><p></p><p class="bulletIndent2">Beta-D-glucan is present in the cell wall of many fungi, including <em>Candida</em>. An assay that detects beta-D-glucan is commercially available and increasingly used in the diagnosis of fungal infections [<a href="#rid59">59-62</a>]. Although the beta-D-glucan assay is sensitive in detecting invasive fungal infections (75 to 80 percent) [<a href="#rid63">63</a>] and in patients with candidemia (approximately 80 percent) [<a href="#rid60">60</a>], it is not specific for <em>Candida</em>; a positive test requires identification of the infecting organism [<a href="#rid7">7</a>].</p><p></p><p class="headingAnchor" id="H942184454"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of proven candidemia or invasive candidiasis is confirmed by positive blood culture or isolation of <em>Candida</em> from skin or parenchymal tissue biopsy in an immunocompromised or immunocompetent patient [<a href="#rid64">64</a>].</p><p>A diagnosis of probable invasive candidiasis can be made in immunocompromised children with a risk factor (eg, neutropenia, hematopoietic cell or solid organ transplant recipient), an episode of candidemia in the previous two weeks, <strong>and</strong> [<a href="#rid64">64</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>At least one of the following clinical features:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Small abscesses in the liver, spleen, brain, or meningeal enhancement on magnetic resonance imaging or computed tomography</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Progressive retinal exudates or vitreal opacities on ophthalmologic examination</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evidence of <em>Candida</em> infection, either:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Positive T2Candida</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Beta-D-glucan ≥80 ng/L detected in at least two consecutive serum samples, provided that other etiologies have been excluded</p><p></p><p class="headingAnchor" id="H3210288907"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The major considerations in the differential diagnosis of candidemia and invasive candidiasis include bacterial sepsis and localized bacterial infection (eg, endocarditis). Bacterial and candidal sepsis or focal infection cannot be differentiated clinically. Microbiologic evaluation is necessary to establish the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/6395.html" rel="external">"Sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p>Pustular skin lesions, which may be suggestive of candidemia (<a class="graphic graphic_picture graphicRef55977 graphicRef75717" href="/z/d/graphic/55977.html" rel="external">picture 3A-B</a>), occur in other infectious and noninfectious conditions. The skin lesions of candidemia usually are painless, but painlessness is nonspecific and Gram stain, culture, or histopathologic examination may be necessary to establish a diagnosis. (See  <a class="medical medical_review" href="/z/d/html/1733.html" rel="external">"Approach to the patient with pustular skin lesions"</a>.)</p><p>Endophthalmitis, another finding suggestive of candidemia (<a class="graphic graphic_picture graphicRef58685 graphicRef73318" href="/z/d/graphic/58685.html" rel="external">picture 2A-B</a>), may be caused by bacteria and other fungi. Cultures, special stains, and other microbiologic studies are necessary to establish the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/3418.html" rel="external">"Bacterial endophthalmitis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/16953.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of fungal endophthalmitis", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">ADDITIONAL EVALUATION</span><span class="headingEndMark"> — </span>We individualize decisions about ophthalmologic examination for children with candidemia and/or invasive candidiasis according to clinical features. Although sight-threatening ocular abnormalities, including chorioretinitis and endophthalmitis, may occur in as many as 8 percent of children with candidemia [<a href="#rid19">19,35,65</a>], professional societies disagree about the value of routine ophthalmologic examination to screen for intraocular infection in patients with candidemia [<a href="#rid66">66,67</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Immune-compromised or critically ill children with confirmed candidemia – We obtain formal ophthalmologic examination, even in those without ocular symptoms [<a href="#rid35">35,66,68</a>].</p><p></p><p class="bulletIndent1">In children who are immune compromised due to neutropenia, the examination should optimally be performed within one week of neutrophil recovery because findings may be minimal during the period of neutropenia [<a href="#rid66">66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immune-competent children with confirmed candidemia – These children do not<strong><em> </em></strong>require ophthalmologic examination if they have only one positive blood culture for <em>Candida</em> and respond rapidly to antifungal therapy. (See  <a class="medical medical_review" href="/z/d/html/6014.html" rel="external">"Candidemia and invasive candidiasis in children: Management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with invasive candidiasis without documented candidemia – We individualize decisions about ophthalmologic examination according to the child's clinical course, immune status, and associated symptoms. Examination is usually warranted if the child is immune compromised, has associated systemic symptoms, or responds poorly to antifungal therapy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neonates – The evaluation of neonates with candidemia is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">"Clinical manifestations and diagnosis of Candida infection in neonates"</a>.)</p><p></p><p class="headingAnchor" id="H3470923359"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/104270.html" rel="external">"Society guideline links: Candidiasis"</a>.)</p><p class="headingAnchor" id="H3939823"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – The term candidemia describes the presence of <em>Candida</em> species in the blood. <em>Candida</em> in a blood culture should prompt a search for the source; it should never be viewed as a contaminant. Invasive candidiasis encompasses both candidemia and deep-seated (ie, visceral) candidiasis (which may occur with or without candidemia). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong><em> – </em>Beyond the neonatal period (ie, in children &gt;28 days),<em> Candida</em> spp are important pathogens in critically ill patients and patients with immunocompromising conditions. The incidence of invasive candidiasis is increased in children younger than one year compared with older children. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1">The infecting strain is usually part of the host's colonizing flora. The distribution of <em>Candida</em> species causing invasive candidiasis varies geographically. <em>Candida albicans</em> is most common, but nonalbicans species are increasingly isolated. In children, <em>Candida parapsilosis</em> is the predominant nonalbicans species in most geographic regions. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Risk factors for invasive candidiasis include immune suppression, damage to the gastrointestinal mucosa, antineoplastic chemotherapy, central venous catheter, receipt of broad-spectrum antibiotics, parenteral nutrition, kidney failure requiring hemodialysis, and mechanical ventilation. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations and clinical suspicion</strong> – Although many children with invasive candidiasis have no obvious clinical manifestations, we suspect invasive candidiasis in children with risk factors who have (see <a class="local">'Clinical manifestations'</a> above and <a class="local">'Clinical suspicion'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unexplained fever or signs of severe sepsis while receiving adequate antibiotics</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Skin lesions suggestive of invasive candidiasis (eg, multiple, nontender, erythematous, pustular or nodular lesions (<a class="graphic graphic_picture graphicRef55977 graphicRef75717" href="/z/d/graphic/55977.html" rel="external">picture 3A-B</a>))</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Eye findings suggestive of invasive candidiasis (<a class="graphic graphic_picture graphicRef58685 graphicRef73318" href="/z/d/graphic/58685.html" rel="external">picture 2A-B</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Multiple focal liver or spleen lesions on imaging for persistent fever</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach to diagnosis</strong> – The tests available to detect invasive candidiasis have important limitations; accurate diagnosis may require multiple tests. We obtain blood cultures of adequate volume from all patients with suspected invasive candidiasis, and other specimens for culture or biopsy as indicated (eg, scrapings from the base of pustules for Gram stain and culture, biopsy of skin or other focal lesions for culture, fungal stains, and histopathologic examination). (See <a class="local">'Approach to laboratory diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of candidemia or invasive candidiasis is confirmed by positive blood culture or isolation of <em>Candida</em> from skin or parenchymal biopsy. The sensitivity of these methods can be low. (See <a class="local">'Diagnosis'</a> above and <a class="local">'Microbiologic studies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Candida</em> in a blood culture should prompt immediate treatment and a search for the source (eg, central venous catheter, gastrointestinal tract, deep-seated infection). (See <a class="local">'Blood cultures'</a> above and  <a class="medical medical_review" href="/z/d/html/6014.html" rel="external">"Candidemia and invasive candidiasis in children: Management", section on 'Choice of antifungal therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infants and children with candidemia who are immune compromised or critically ill generally should undergo a formal ophthalmologic examination for chorioretinitis, whether or not they have ocular symptoms. (See <a class="local">'Additional evaluation'</a> above.)</p><p></p><p class="headingAnchor" id="H1592359163"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate would like to acknowledge Carol A Kauffman, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Clancy CJ, Nguyen MH. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013; 56:1284.</a></li><li><a class="nounderline abstract_t">Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis 1995; 20:571.</a></li><li><a class="nounderline abstract_t">Blyth CC, Chen SC, Slavin MA, et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 2009; 123:1360.</a></li><li><a class="nounderline abstract_t">Warris A, Pana ZD, Oletto A, et al. Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study. Pediatr Infect Dis J 2020; 39:114.</a></li><li><a class="nounderline abstract_t">Benedict K, Roy M, Kabbani S, et al. Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009-2015. J Pediatric Infect Dis Soc 2018; 7:e78.</a></li><li><a class="nounderline abstract_t">Lausch KR, Schultz Dungu KH, Callesen MT, et al. Pediatric Candidemia Epidemiology and Morbidities: A Nationwide Cohort. Pediatr Infect Dis J 2019; 38:464.</a></li><li><a class="nounderline abstract_t">Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med 2015; 373:1445.</a></li><li><a class="nounderline abstract_t">Arendrup MC. Epidemiology of invasive candidiasis. Curr Opin Crit Care 2010; 16:445.</a></li><li><a class="nounderline abstract_t">Tsay SV, Mu Y, Williams S, et al. Burden of Candidemia in the United States, 2017. Clin Infect Dis 2020; 71:e449.</a></li><li><a class="nounderline abstract_t">Toda M, Williams SR, Berkow EL, et al. Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016. MMWR Surveill Summ 2019; 68:1.</a></li><li><a class="nounderline abstract_t">Larru B, Gong W, Vendetti N, et al. Bloodstream Infections in Hospitalized Children: Epidemiology and Antimicrobial Susceptibilities. Pediatr Infect Dis J 2016; 35:507.</a></li><li><a class="nounderline abstract_t">Verduyn Lunel FM, Meis JF, Voss A. Nosocomial fungal infections: candidemia. Diagn Microbiol Infect Dis 1999; 34:213.</a></li><li><a class="nounderline abstract_t">Lamoth F, Kontoyiannis DP. The Candida auris Alert: Facts and Perspectives. J Infect Dis 2018; 217:516.</a></li><li><a class="nounderline abstract_t">Vallabhaneni S, Jackson BR, Chiller TM. Candida auris: An Emerging Antimicrobial Resistance Threat. Ann Intern Med 2019; 171:432.</a></li><li><a class="nounderline abstract_t">Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20:133.</a></li><li><a class="nounderline abstract_t">Dutta A, Palazzi DL. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J 2011; 30:664.</a></li><li><a class="nounderline abstract_t">Dotis J, Prasad PA, Zaoutis T, Roilides E. Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children. Pediatr Infect Dis J 2012; 31:557.</a></li><li><a class="nounderline abstract_t">Steinbach WJ, Roilides E, Berman D, et al. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J 2012; 31:1252.</a></li><li><a class="nounderline abstract_t">Silvester EJ, Watanabe MMY, Pittet LF, et al. Candidemia in Children: A 16-year Longitudinal Epidemiologic Study. Pediatr Infect Dis J 2021; 40:537.</a></li><li><a class="nounderline abstract_t">Oeser C, Lamagni T, Heath PT, et al. The epidemiology of neonatal and pediatric candidemia in England and Wales, 2000-2009. Pediatr Infect Dis J 2013; 32:23.</a></li><li><a class="nounderline abstract_t">Palazzi DL, Arrieta A, Castagnola E, et al. Candida speciation, antifungal treatment and adverse events in pediatric invasive candidiasis: results from 441 infections in a prospective, multi-national study. Pediatr Infect Dis J 2014; 33:1294.</a></li><li><a class="nounderline abstract_t">Warris A. Candida auris, what do paediatricians need to know? Arch Dis Child 2018; 103:891.</a></li><li><a class="nounderline abstract_t">Berrio I, Caceres DH, Coronell R W, et al. Bloodstream Infections With Candida auris Among Children in Colombia: Clinical Characteristics and Outcomes of 34 Cases. J Pediatric Infect Dis Soc 2021; 10:151.</a></li><li><a class="nounderline abstract_t">Cook A, Ferreras-Antolin L, Adhisivam B, et al. Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study. Med Mycol 2023; 61.</a></li><li><a class="nounderline abstract_t">Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001; 33:177.</a></li><li><a class="nounderline abstract_t">Playford EG, Marriott D, Nguyen Q, et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 2008; 36:2034.</a></li><li><a class="nounderline abstract_t">Zaoutis TE, Prasad PA, Localio AR, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis 2010; 51:e38.</a></li><li><a class="nounderline abstract_t">Pana ZD, Kotzadamis D, Roilides E. Invasive Candidiasis in Pediatric Intensive Care Unit: More Challenges. Pediatr Infect Dis J 2018; 37:1309.</a></li><li><a class="nounderline abstract_t">Plantinga TS, Johnson MD, Scott WK, et al. Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J Infect Dis 2012; 205:934.</a></li><li><a class="nounderline abstract_t">Kumar V, Cheng SC, Johnson MD, et al. Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia. Nat Commun 2014; 5:4675.</a></li><li><a class="nounderline abstract_t">Johnson MD, Plantinga TS, van de Vosse E, et al. Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. Clin Infect Dis 2012; 54:502.</a></li><li><a class="nounderline abstract_t">Barter DM, Johnston HL, Williams SR, et al. Candida Bloodstream Infections Among Persons Who Inject Drugs - Denver Metropolitan Area, Colorado, 2017-2018. MMWR Morb Mortal Wkly Rep 2019; 68:285.</a></li><li><a class="nounderline abstract_t">Zhang AY, Shrum S, Williams S, et al. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor-Active Surveillance in Selected Sites, United States, 2014-2017. Clin Infect Dis 2020; 71:1732.</a></li><li><a class="nounderline abstract_t">Fisher BT, Ross RK, Roilides E, et al. Failure to Validate a Multivariable Clinical Prediction Model to Identify Pediatric Intensive Care Unit Patients at High Risk for Candidemia. J Pediatric Infect Dis Soc 2016; 5:458.</a></li><li><a class="nounderline abstract_t">Fierro JL, Prasad PA, Fisher BT, et al. Ocular manifestations of candidemia in children. Pediatr Infect Dis J 2013; 32:84.</a></li><li><a class="nounderline abstract_t">Singhi S, Deep A. Invasive candidiasis in pediatric intensive care units. Indian J Pediatr 2009; 76:1033.</a></li><li><a class="nounderline abstract_t">Hegde SV, Dillman JR, Lopez MJ, Strouse PJ. Imaging of multifocal liver lesions in children and adolescents. Cancer Imaging 2013; 12:516.</a></li><li><a class="nounderline abstract_t">Yen TY, Huang LM, Lee PI, et al. Clinical characteristics of hepatosplenic fungal infection in pediatric patients. J Microbiol Immunol Infect 2011; 44:296.</a></li><li><a class="nounderline abstract_t">Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54:1240.</a></li><li><a class="nounderline abstract_t">Buttery JP. Blood cultures in newborns and children: optimising an everyday test. Arch Dis Child Fetal Neonatal Ed 2002; 87:F25.</a></li><li><a class="nounderline abstract_t">Miller JM, Binnicker MJ, Campbell S, et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018; 67:e1.</a></li><li><a class="nounderline abstract_t">Schelonka RL, Moser SA. Time to positive culture results in neonatal Candida septicemia. J Pediatr 2003; 142:564.</a></li><li><a class="nounderline abstract_t">Shepard JR, Addison RM, Alexander BD, et al. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 2008; 46:50.</a></li><li><a class="nounderline abstract_t">Arvanitis M, Anagnostou T, Fuchs BB, et al. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev 2014; 27:490.</a></li><li class="breakAll">US Food and Drug Administration. FDA news release. FDA allows marketing of the first test to identify five yeast pathogens directly from a blood sample. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm415728.htm (Accessed on September 24, 2014).</li><li><a class="nounderline abstract_t">Neely LA, Audeh M, Phung NA, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med 2013; 5:182ra54.</a></li><li><a class="nounderline abstract_t">Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis 2015; 60:892.</a></li><li><a class="nounderline abstract_t">Walsh TJ, Katragkou A, Chen T, et al. Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment. J Fungi (Basel) 2019; 5.</a></li><li><a class="nounderline abstract_t">Hamula CL, Hughes K, Fisher BT, et al. T2Candida Provides Rapid and Accurate Species Identification in Pediatric Cases of Candidemia. Am J Clin Pathol 2016; 145:858.</a></li><li><a class="nounderline abstract_t">Dien Bard J, McElvania TeKippe E. Diagnosis of Bloodstream Infections in Children. J Clin Microbiol 2016; 54:1418.</a></li><li><a class="nounderline abstract_t">Fisher BT, Boge CLK, Xiao R, et al. Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents. Clin Infect Dis 2022; 75:248.</a></li><li><a class="nounderline abstract_t">Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002; 40:2483.</a></li><li><a class="nounderline abstract_t">McMullan R, Metwally L, Coyle PV, et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 2008; 46:890.</a></li><li><a class="nounderline abstract_t">Lau A, Halliday C, Chen SC, et al. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol 2010; 48:811.</a></li><li><a class="nounderline abstract_t">Matthews RC. Comparative assessment of the detection of candidal antigens as a diagnostic tool. J Med Vet Mycol 1996; 34:1.</a></li><li><a class="nounderline abstract_t">Reiss E, Obayashi T, Orle K, et al. Non-culture based diagnostic tests for mycotic infections. Med Mycol 2000; 38 Suppl 1:147.</a></li><li><a class="nounderline abstract_t">Steinbach WJ. Blood-based Diagnosis of Invasive Fungal Infections in Immunocompromised/Oncology Patients. Pediatr Infect Dis J 2015; 34:1020.</a></li><li><a class="nounderline abstract_t">Marchetti O, Lamoth F, Mikulska M, et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47:846.</a></li><li><a class="nounderline abstract_t">Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39:199.</a></li><li><a class="nounderline abstract_t">Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1--&gt;3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654.</a></li><li><a class="nounderline abstract_t">Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1--&gt;3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years. Clin Infect Dis 2008; 46:1864.</a></li><li><a class="nounderline abstract_t">Mohr JF, Sims C, Paetznick V, et al. Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol 2011; 49:58.</a></li><li><a class="nounderline abstract_t">Karageorgopoulos DE, Vouloumanou EK, Ntziora F, et al. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011; 52:750.</a></li><li><a class="nounderline abstract_t">Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 2020; 71:1367.</a></li><li><a class="nounderline abstract_t">Zaoutis TE, Greves HM, Lautenbach E, et al. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004; 23:635.</a></li><li><a class="nounderline abstract_t">Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.</a></li><li><a class="nounderline abstract_t">Breazzano MP, Bond JB 3rd, Bearelly S, et al. American Academy of Ophthalmology Recommendations on Screening for Endogenous Candida Endophthalmitis. Ophthalmology 2022; 129:73.</a></li><li><a class="nounderline abstract_t">Krishna R, Amuh D, Lowder CY, et al. Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis? Eye (Lond) 2000; 14 ( Pt 1):30.</a></li></ol></div><div id="topicVersionRevision">Topic 5976 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23315320" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7756477" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Candidemia in a pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19403503" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31725552" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29522195" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30281546" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pediatric Candidemia Epidemiology and Morbidities: A Nationwide Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26444731" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Invasive Candidiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20711075" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Epidemiology of invasive candidiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32107534" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Burden of Candidemia in the United States, 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31557145" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26766146" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Bloodstream Infections in Hospitalized Children: Epidemiology and Antimicrobial Susceptibilities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10403101" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Nosocomial fungal infections: candidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29390110" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The Candida auris Alert: Facts and Perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31357215" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Candida auris: An Emerging Antimicrobial Resistance Threat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17223626" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Epidemiology of invasive candidiasis: a persistent public health problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21372750" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22333703" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22982980" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33591077" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Candidemia in Children: A 16-year Longitudinal Epidemiologic Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23241987" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The epidemiology of neonatal and pediatric candidemia in England and Wales, 2000-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24892850" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Candida speciation, antifungal treatment and adverse events in pediatric invasive candidiasis: results from 441 infections in a prospective, multi-national study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29545411" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Candida auris, what do paediatricians need to know?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32373928" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Bloodstream Infections With Candida auris Among Children in Colombia: Clinical Characteristics and Outcomes of 34 Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36881725" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11418877" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18552700" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20636126" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30199481" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Invasive Candidiasis in Pediatric Intensive Care Unit: More Challenges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22301633" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Toll-like receptor 1 polymorphisms increase susceptibility to candidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25197941" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22144535" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30921302" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Candida Bloodstream Infections Among Persons Who Inject Drugs - Denver Metropolitan Area, Colorado, 2017-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31676903" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor-Active Surveillance in Selected Sites, United States, 2014-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26407259" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Failure to Validate a Multivariable Clinical Prediction Model to Identify Pediatric Intensive Care Unit Patients at High Risk for Candidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23241990" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Ocular manifestations of candidemia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19907936" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Invasive candidiasis in pediatric intensive care units.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23400044" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Imaging of multifocal liver lesions in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21524963" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Clinical characteristics of hepatosplenic fungal infection in pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22431804" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Performance of Candida real-time polymerase chain reaction,β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12091285" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Blood cultures in newborns and children: optimising an everyday test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29955859" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12756391" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Time to positive culture results in neonatal Candida septicemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17977998" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24982319" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Molecular and nonmolecular diagnostic methods for invasive fungal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24982319" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Molecular and nonmolecular diagnostic methods for invasive fungal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23616121" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25586686" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30678324" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27247378" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : T2Candida Provides Rapid and Accurate Species Identification in Pediatric Cases of Candidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26818669" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Diagnosis of Bloodstream Infections in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35134165" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12089267" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18260751" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20042634" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8786465" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Comparative assessment of the detection of candidal antigens as a diagnostic tool.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11204140" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Non-culture based diagnostic tests for mycotic infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26083591" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Blood-based Diagnosis of Invasive Fungal Infections in Immunocompromised/Oncology Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21927034" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15307029" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16080087" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Multicenter clinical evaluation of the (1--&gt;3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18462174" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Reappraisal of the serum (1--&gt;3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21048005" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21367728" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31802125" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15247602" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Risk factors for disseminated candidiasis in children with candidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26679628" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34293405" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : American Academy of Ophthalmology Recommendations on Screening for Endogenous Candida Endophthalmitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10755096" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis?</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
